Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Not Confirmed
Not Confirmed
11-13 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Industry Trade Show
Not Confirmed
11-13 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities
26 Apr 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/fervent-pharmaceuticals-commences-virtual-at-home-phase-2-clinical-trial-of-a-peri--and-post-menopausal-therapy-for-treating-hot-flashes-and-night-sweats-301533095.html
Details:
FP-101 is a non-hormonal/non-herbal/non-antidepressant product for the treatment of vasomotor symptoms associated with menopause and hot flashes. This indication represents an unmet medical need in a substantial and motivated market.
Lead Product(s): FP-101
Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Brand Name: FP-101
Study Phase: Phase IIProduct Type: Small molecule
Sponsor: IQVIA
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable April 26, 2022
Lead Product(s) : FP-101
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : IQVIA
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : FP-101 is a non-hormonal/non-herbal/non-antidepressant product for the treatment of vasomotor symptoms associated with menopause and hot flashes. This indication represents an unmet medical need in a substantial and motivated market.
Brand Name : FP-101
Molecule Type : Small molecule
Upfront Cash : Not Applicable
April 26, 2022
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?